(Q28271304)

English

Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer

scientific article

In more languages
default values for all languages
No label defined

No description defined

Statements

Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer (English)
0 references
Alberto A Chiappori
0 references
Eric Haura
0 references
Francisco A Rodriguez
0 references
David Boulware
0 references
Rachna Kapoor
0 references
Anthony M Neuger
0 references
Richard Lush
0 references
Barbara Padilla
0 references
Michelle Burton
0 references
Charles Williams
0 references
George Simon
0 references
Scott Antonia
0 references
Daniel M Sullivan
0 references
Gerold Bepler
0 references
1 March 2008
0 references
14
0 references
5
0 references
1464-9
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit